FindTrial
Sign In

The effectiveness and safety of Innotech Hormone Pump

Multicenter clinical study to evaluate the effectiveness and safety of Infotech Hormone Pump

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027378
Enrollment
Unknown
Registered
2019-11-11
Start date
2017-12-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IHH (Kalman)

Interventions

Case series:Hormone pump

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 36 Years

Inclusion criteria

Inclusion criteria: 1. The testing subjects participating the clinical trials are voluntary and informed consent; 2. Aged 16 to 50 years old; 3. LH & FSH <=1 mIU/m, IHH, have stop HCG,HMG, hormone therapy for at least 1 week.

Exclusion criteria

Exclusion criteria: 1. No other severe disease such as chronic disease of liver and kidney; 2. Cryptorchid or HCG stimulation test testosterone<1.0 ng/mL; 3. Multiple hormone deficiencies cause by hypothalamus-pituitary system; 4. GHD, no matter use or not use GH; 5. Hyper-gonadotropin Hypogonadism; 6. Psychopath; 7. Patients undergoing anti-depression, immunosuppressive therapy,chemotherapy,radiotherapy; 8. Patient who is allergic to Gonadorelin; 9. Cancer patients undergoing hormone treatment.

Design outcomes

Primary

MeasureTime frame
accurancy;—

Secondary

MeasureTime frame
Serum sex hormone levels;—

Countries

China

Contacts

Public ContactWu Xueyan

Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

wsheyan@vip.sina.com+86 13901397470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026